Myxoid liposarcoma

Active Research Protocols

  1. 08-C-0080 – SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014